Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

Boehringer and InterMune data on IPF drugs impress

May 19, 2014 Research and Development, Sales and Marketing Boehringer Ingelheim, InterMune, idiopathic pulmonary fibrosis

Two new medicines for a generally fatal lung disease, known as idiopathic pulmonary fibrosis and made by Boehringer and InterMune, …
News
ownfone

Braille phone launched by UK developer

May 19, 2014 Manufacturing and Production, Medical Communications, Research and Development Apple

British technology firm OwnFone has launched what it says is the first commercially available Braille phone. The device, which shares …
News
Novartis logo

Novartis agrees Gleevec patent deal

May 19, 2014 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Gleevec, India, Novartis, Sun Pharma, patent

Novartis has settled patent litigation with Sun Pharmaceutical Industries in the US, paving the way for the Indian company’s subsidiary …
News
AstraZeneca logo

AstraZeneca rejects Pfizer’s ‘final offer’

May 19, 2014 Medical Communications, Research and Development, Sales and Marketing AstraZeneca, MPs, Pfizer, R&D, UK, science, takeover

AstraZeneca has this morning rejected a new bid from Pfizer that could have seen the US giant pay £69 billion …
News
Ian Read

Science left behind in Pfizer-AstraZeneca saga

May 18, 2014 Medical Communications, Research and Development, Sales and Marketing AstraZeneca, MPs, Pfizer, Wellcome Trust, science

With all the posturing, debates and endless comment on the commercial aspects of a $106 billion deal between Pfizer and …
News
Pfizer New York HQ

Pfizer to submit breast cancer drug

May 18, 2014 Research and Development, Sales and Marketing Pfizer, breast cancer, femara, palbociclib

Pfizer, currently in the middle of trying to acquire AstraZeneca for $106 billion, says it will soon submit its new …
News
Lord Maurice Saatchi

Clinical evidence revisited

May 18, 2014 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, Lord Saatchi, Medical Innovation Bill, clinical trials

One of the most important words in the English language is ‘evidence’. It has had a seismic effect on the …
Feature
FDA logo

Heartbreak for Novartis as FDA rejects drug

May 18, 2014 Research and Development, Sales and Marketing GSK, Novartis, heart drug

Novartis has been delivered a blow by the US Food and Drug Administration as the regulator says it needs further …
News
AstraZeneca's Cambridge Biomedical campus

AstraZeneca signs UK research deal

May 16, 2014 Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cambridge, Pfizer

The UK’s Medical Research Council (MRC) Laboratory of Molecular Biology (LMB) and AstraZeneca will join forces to help discover new …
News
roche_logo_shadow_7

Roche gets oncology boost with cancer vaccine

May 16, 2014 Research and Development, Sales and Marketing ASCO, Roche, bladder cancer, oncology

Roche’s most advanced experimental cancer immunotherapy has had impressive results in a small Phase I trial, reducing tumour size in …
News
boehringer_angle_22

Giotrif increases lung cancer survival

May 16, 2014 Research and Development, Sales and Marketing Boehringer, Iressa, Roche, Tarceva, afatinib, giotrif, lung cancer

Boehringer Ingelheim is trumpeting overall survival results from a new analysis of two late-stage studies involving Giotrif in lung cancer …
News
paul-williams600xx400-600-49-0

K-V Pharmaceutical hires head of women’s healthcare

May 15, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing KV, paul williams

K-V Pharmaceutical (KV) has hired industry veteran and former Actavis head Paul Williams to lead its women’s healthcare division.  Williams …
Appointment
Medimmune image

MedImmune signs Incyte oncology deal

May 15, 2014 Research and Development, Sales and Marketing AstraZeneca, Cancer, Incyte, MedImmune, oncology

MedImmune, the global biologics R&D arm of AstraZeneca, is to put one of its oncology immunotherapies into development in combination …
News
Willetts image

Pfizer: ‘fewer scientists’ after merger

May 14, 2014 Research and Development, Sales and Marketing AstraZeneca, Pfizer, Read, Soriot, UK, Willetts, merger, takeover

Pfizer’s proposed takeover of AstraZeneca would result in there being fewer scientists from both companies in the UK than currently …
News
GSK image

More late-stage anguish for GSK heart drug

May 14, 2014 Research and Development, Sales and Marketing GSK, Patrick Vallance, darapladib, heart

GlaxoSmithKline’s experimental heart drug darapladib has failed to meet its primary endpoint in a Phase III trial for the second …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026